Cargando…

Hyperglycemia-related advanced glycation end-products is associated with the altered phosphatidylcholine metabolism in osteoarthritis patients with diabetes

To test whether type 2 diabetic patients have an elevated level of advanced glycation end-products (AGEs) and responsible for altered phosphatidylcholine metabolism, which we recently found to be associated with osteoarthritis (OA) and diabetes mellitus (DM), synovial fluid (SF) and plasma samples w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Weidong, Randell, Edward W., Sun, Guang, Likhodii, Sergei, Liu, Ming, Furey, Andrew, Zhai, Guangju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595284/ https://www.ncbi.nlm.nih.gov/pubmed/28898260 http://dx.doi.org/10.1371/journal.pone.0184105

Ejemplares similares

A classification modeling approach for determining metabolite signatures in osteoarthritis
por: Rockel, Jason S., et al.
Publicado: (2018)

Classification of osteoarthritis phenotypes by metabolomics analysis
por: Zhang, Weidong, et al.
Publicado: (2014)

Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients
por: Zhai, Guangju, et al.
Publicado: (2019)

An evolutionary learning and network approach to identifying key metabolites for osteoarthritis
por: Hu, Ting, et al.
Publicado: (2018)

Activation of The Phosphatidylcholine to Lysophosphatidylcholine Pathway Is Associated with Osteoarthritis Knee Cartilage Volume Loss Over Time
por: Zhai, Guangju, et al.
Publicado: (2019)

Endotypes of primary osteoarthritis identified by plasma metabolomics analysis
por: Werdyani, Salem, et al.
Publicado: (2020)

Alteration of Metabolic Pathways in Osteoarthritis
por: Zhai, Guangju
Publicado: (2019)

Differential correlation network analysis identified novel metabolomics signatures for non-responders to total joint replacement in primary osteoarthritis patients
por: Costello, Christie A., et al.
Publicado: (2020)

Protective Effects of Phosphatidylcholine against Hepatic and Renal Cell Injury from Advanced Glycation End Products
por: Choi, Jihye, et al.
Publicado: (2022)

Differential metabolomics analysis allows characterization of diversity of metabolite networks between males and females
por: Li, Zimin, et al.
Publicado: (2018)

Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
por: Yamagishi, Sho-ichi, et al.
Publicado: (2018)

Baseline urinary KIM-1 concentration in detecting acute kidney injury should be interpreted with patient pre-existing nephropathy
por: Huang, Yun, et al.
Publicado: (2019)

Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans
por: Perkins, Ryan K., et al.
Publicado: (2019)

Serum metabolic biomarkers distinguish metabolically healthy peripherally obese from unhealthy centrally obese individuals
por: Gao, Xiang, et al.
Publicado: (2016)

Differential metabolomics networks analysis of menopausal status
por: Cui, Xiujuan, et al.
Publicado: (2019)

Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes
por: Chang, Chia-Chu, et al.
Publicado: (2017)

Individual participant data meta-analysis of metabolomics on sustained knee pain in primary osteoarthritis patients
por: Costello, Christie A, et al.
Publicado: (2022)

Metabolomic analysis coupled with extreme phenotype sampling identified that lysophosphatidylcholines are associated with multisite musculoskeletal pain
por: Liu, Ming, et al.
Publicado: (2021)

Advanced glycation endproducts in the development of osteoarthritis
por: DeGroot, J, et al.
Publicado: (2004)

Advanced glycation end products and diabetes and other metabolic indicators
por: Jiang, Tian, et al.
Publicado: (2022)

Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
por: Yao, Dachun, et al.
Publicado: (2010)

Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles
por: Rom, Slava, et al.
Publicado: (2020)

Advanced Glycation End-Products and Hyperglycemia Increase Angiopoietin-2 Production by Impairing Angiopoietin-1-Tie-2 System
por: Puddu, Alessandra, et al.
Publicado: (2019)

Pentosidine, an Advanced Glycation End-Product, May Reflect Clinical and Morphological Features of Hand Osteoarthritis
por: Braun, Martin, et al.
Publicado: (2012)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Advanced glycation end product signaling and metabolic complications: Dietary approach
por: Khan, Mohammad Idreesh, et al.
Publicado: (2023)

Macrophage migration inhibitory factor may play a protective role in osteoarthritis
por: Liu, Ming, et al.
Publicado: (2021)

Hyperglycemia-induced accumulation of advanced glycosylation end products in fibroblast-like synoviocytes promotes knee osteoarthritis
por: Li, Qingxian, et al.
Publicado: (2021)

Author Correction: Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles
por: Rom, Slava, et al.
Publicado: (2020)

Advanced Glycation End Products and Bone Metabolism in Patients with Chronic Kidney Disease
por: Quadros, Kélcia R. S., et al.
Publicado: (2023)

Receptor for the Advanced Glycation End Products (RAGE) Pathway in Adipose Tissue Metabolism
por: Gutowska, Klaudia, et al.
Publicado: (2023)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
por: Papagrigoraki, Anastasia, et al.
Publicado: (2017)

Toxicity of advanced glycation end products (Review)
por: Kuzan, Aleksandra
Publicado: (2021)

Advanced Glycation End Products in Health and Disease
por: Reddy, V. Prakash, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

SMAD3 Is Associated with the Total Burden of Radiographic Osteoarthritis: The Chingford Study
por: Aref-Eshghi, Erfan, et al.
Publicado: (2014)

Impairment of glyoxalase-1, an advanced glycation end-product detoxifying enzyme, induced by inflammation in age-related osteoarthritis
por: Trellu, Sabine, et al.
Publicado: (2019)

The role of metabolomics in precision medicine of osteoarthritis: How far are we?
por: Zhai, Guangju
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4shpvkqeal3o0eqibrflejjn2k